Skip to content

BREPHAR

Absorbed by MULTIPHARMA on 13-06-2024 KBO/BCE: BE 0875.406.885

Lifetime

18 annual accounts with figures on one time axis
peak of €163,949 in 2006
€39,286▼ 55.2%
lowest -€11,632 in 2015
€33,079▼ 43.8%
peak of €490,736 in 2023
€490,736▲ 7.2%
€23,859▼ 26.3%
peak of 1.8 FTE in 2014
-not published
Board3 names since 2005
2 directors and 1 other
Owners
100%
Documentsfilings and deeds
24-07-20247 days before the deadline
2023financial year
Gross margin from €87,653 to €39,286Result from €58,860 to €33,0791 director appointed, 1 statutory auditor appointed, 2 resign… 19-10 (director) and (director) appointed 04-10Debts from €32,362 to €23,859Cash from €304,818 to €427,375

Key points

from the 2023 annual accounts, the last ones filed

Profit

8 years
201820192020202120222023

8 profitable years in a row. Profit of €33,079 in financial year 2023.

Filings

18 annual accounts since 2006
AprilJune31 JulyOctober201020152020

Seven of the last ten came late. The 2015 accounts came in latest, 31 days after the end of the period.

Board and ownership

Director, since 02-10-2023
Director
Auditor,
Board & ownership

Recent changes

Merger: absorbed by MULTIPHARMA MULTIPHARMA holds all the shares · General meeting of 13-06-2024 · Gazette deed
Merger proposal: to be absorbed by MULTIPHARMA Gazette deed
Registered office moved from Geraardsbergen to Anderlecht The registered office moved from Vredestraat 6, 9500 Geraardsbergen to Marie Curiesquare 30, 1070 Anderlecht · General meeting of 16-10-2023 · Gazette deed
1 director appointed, 1 statutory auditor appointed, 2 resignations and resign · and (statutory auditor) appointed · acts as permanent representative · General meeting of 02-10-2023 · Gazette deed
All 30 events

Official details

Source: KBO
Status
Absorbed by MULTIPHARMAmerger by absorption, April 2024
Activity
“Het oprichten, overnemen en uitbaten van apotheken, aankoop en verkoop, invoer en uitvoer, fabricatie…” (deed in French)From the articles, 10 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2023

≈ €140,000estimated
€514,595▲ 5.0%
Filing
Filed on 24-07-2024
Financials

Insights on BREPHAR

Absorbed by MULTIPHARMA in April 2024. The last annual accounts are for financial year 2023.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BREPHAR

What is the company number of BREPHAR?
The company number of BREPHAR is 0875.406.885. The VAT number is the same number with BE in front: BE 0875.406.885.
What is the legal form of BREPHAR?
The KBO register gives BREPHAR the legal form “SRL”.
Is BREPHAR still active?
No. Absorbed in a merger on 13-06-2024.Company details
How many employees did BREPHAR have?
BREPHAR had an average of 1 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of BREPHAR?
The turnover in financial year 2023 is about €140,000. This figure is estimated from the gross margin of €39,286 and 888 comparable companies of the same size. It probably lies between €75,000 and €280,000. It is a rough estimate.
Is BREPHAR profitable?
In financial year 2023, BREPHAR made a profit of €33,079.
Where can I find the annual accounts of BREPHAR?
BREPHAR filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

Keep this company with today's facts in a case file.